Correction to: British Journal of Cancer (2015) 113, 645–652; doi:10.1038/bjc.2015.246; published online 14 July 2015
The authors have become aware that Dr F Grabellus’s affiliation is not ‘Zentrum fuer Pathologie Essen-Mitte, ZPEM, Am Deimelsberg 34a, D-45276 Essen, Germany’ (as it appears in the above paper) but ‘Institute of Pathology and Neuropathology, University Hospital of Essen, University of Duisburg-Essen, Hufelandstrasse 55, D-45122 Essen, Germany’. The error has now been corrected.
Change history
22 December 2015
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/bjc.2015.246
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
About this article
Cite this article
Podleska, L., Funk, K., Umutlu, L. et al. Erratum: TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature. Br J Cancer 113, 1747 (2015). https://doi.org/10.1038/bjc.2015.461
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2015.461